Martela (MARAS) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
12 Nov, 2025Executive summary
Revenue for January–September 2025 increased by 14.5% year-over-year to EUR 70.9 million, with operating result improving to EUR -1.2 million from EUR -4.8 million.
Third quarter operating result turned positive at EUR 0.3 million, compared to EUR -0.9 million in the same period last year.
Efficiency measures and cost reductions contributed to improved profitability, despite ongoing market challenges.
Revenue growth was driven by Finland, Sweden, and Norway, while new orders slightly declined by about 1% year-over-year.
Financial highlights
Q3 2025 revenue was EUR 20.7 million, flat year-over-year; operating profit margin improved to 1.3% from -4.5%.
Net result for January–September was EUR -2.9 million, a significant improvement from EUR -6.1 million year-over-year.
Earnings per share for January–September improved to EUR -0.63 from EUR -1.32.
Cash flow from operating activities was EUR 1.6 million, up from EUR -0.3 million in the prior year.
Outlook and guidance
Full-year 2025 revenue is expected to increase compared to the previous year, with comparable operating profit anticipated to be close to zero.
Management remains focused on profitability and cash flow improvements for the remainder of 2025.
Latest events from Martela
- Revenue up 8.1% in 2025, but net loss persists; profitability targeted for 2026.MARAS
Q4 202525 Feb 2026 - Revenue up 21.8% in H1 2025, with Q2 operating result returning to profit.MARAS
Q2 202513 Aug 2025 - Revenue and profit fell, but Q3 new orders increased and outlook stabilizes.MARAS
Q3 202413 Jun 2025 - Q2 revenue rose 8.3% and losses narrowed; full-year revenue and profit growth expected.MARAS
Q2 202413 Jun 2025 - Revenue up 26.6% in Q1 2025, but profitability remains challenged amid ongoing restructuring.MARAS
Q1 20256 Jun 2025 - 2024 saw steep losses and margin pressure, but order growth and restructuring signal a cautious recovery.MARAS
Q4 20245 Jun 2025